High BP Visit-to-Visit Variability Linked to Dementia Risk in Late Life
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
TUESDAY, Oct. 31, 2023 -- High visit-to-visit blood pressure (BP) variability (BPV) is associated with increased dementia risk in late life, according to a study published online Oct. 30 in JAMA Network Open.
Melina G. H. E. den Brok, M.D., from the Radboud University Medical Center in Nijmegen, Netherlands, and colleagues examined whether visit-to-visit BPV at different ages was associated with incident dementia risk in a prospective cohort study. Participants were aged 65 years or older at enrollment and underwent biennial medical assessments, including cognitive screening. The analysis included 820 participants; the mean follow-up was 32.2 years, with 27,885 person-years from midlife to death.
The researchers found that 45.4 percent of the participants developed dementia. There was no association seen for higher BPV with higher lifetime dementia risk at age 60, 70, or 80 years. BPV was associated with higher dementia risk at age 90 years (hazard ratio, 1.35). Associations of high BPV with higher dementia risk were present only at older ages in meta-regression of hazard ratios calculated separately for each age (60 to 90 years); the association of systolic BP with dementia shifted direction with older age, from incremental to inverse.
"This study was unique in assessing the associations of BPV with lifetime dementia risk at multiple ages from midlife to late life, underlining the necessity of additional long-term studies with more diverse samples to confirm the age dependency of this association, identify underlying mechanisms, and corroborate this study's conclusion," the authors write.
Several authors disclosed ties to the pharmaceutical and medical device industries.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted October 2023
Read this next
Self-Administered Gerocognitive Exam Improves Detection of Cognitive Issues in Primary Care
TUESDAY, July 2, 2024 -- A self-administered gerocognitive examination (SAGE) is easily incorporated into primary care provider (PCP) visits, and its use significantly increases...
Emergence of Psychosis in Alzheimer Disease Linked to Elevations in p-tau181
MONDAY, July 1, 2024 -- For individuals with Alzheimer disease (AD), the emergence of psychosis is associated with elevations in levels of plasma tau phosphorylated at threonine...
Lower Cognitive Function in Adolescence Linked to Stroke Risk
FRIDAY, June 28, 2024 -- Lower cognitive function in adolescence is associated with increased risk of early-onset stroke, according to a study published online June 27 in the...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.